Jenoptik AG
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-69.6% vs price
Base Case (Median)
-46.3% vs price
Bull Case (75th pct.)
-22.0% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $0.96 | -97.8% | High (40%) |
| PE Comparable | $35.34 | -18.9% | Medium (25%) |
| Growth Trajectory DCF | $17.34 | -60.2% | Medium (20%) |
| Graham Number | $23.40 | -46.3% | Low (10%) |
| EV/EBITDA | $32.65 | -25.1% | Medium (20%) |
| EV/FCF | $39.21 | -10.1% | Medium (20%) |
| Earnings Power Value | $9.17 | -79.0% | Medium (50%) |
Based on 7 out of 8 methods, JNPKF appears overvalued at the current price of $43.60. The base case fair value of $23.40 implies 46.3% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.